[go: up one dir, main page]

BRPI0818459A2 - Composição farmacêutica adequada para uso oftálmico. - Google Patents

Composição farmacêutica adequada para uso oftálmico.

Info

Publication number
BRPI0818459A2
BRPI0818459A2 BRPI0818459-3A BRPI0818459A BRPI0818459A2 BR PI0818459 A2 BRPI0818459 A2 BR PI0818459A2 BR PI0818459 A BRPI0818459 A BR PI0818459A BR PI0818459 A2 BRPI0818459 A2 BR PI0818459A2
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
composition suitable
ophthalmic use
ophthalmic
pharmaceutical
Prior art date
Application number
BRPI0818459-3A
Other languages
English (en)
Inventor
Arindam Halder
Ajay Jaysingh Khopade
Subhas Balaram Bhowmick
Original Assignee
Sun Pharma Advanced Res Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharma Advanced Res Co Ltd filed Critical Sun Pharma Advanced Res Co Ltd
Publication of BRPI0818459A2 publication Critical patent/BRPI0818459A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
BRPI0818459-3A 2007-10-16 2008-10-15 Composição farmacêutica adequada para uso oftálmico. BRPI0818459A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN2061MU2007 2007-10-16
PCT/IN2008/000671 WO2009084021A2 (en) 2007-10-16 2008-10-15 Novel ophthalmic compositions

Publications (1)

Publication Number Publication Date
BRPI0818459A2 true BRPI0818459A2 (pt) 2015-04-14

Family

ID=40824837

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0818459-3A BRPI0818459A2 (pt) 2007-10-16 2008-10-15 Composição farmacêutica adequada para uso oftálmico.

Country Status (18)

Country Link
US (2) US9629852B2 (pt)
EP (1) EP2197449A4 (pt)
JP (1) JP5646331B2 (pt)
KR (1) KR101510185B1 (pt)
CN (1) CN101835473B (pt)
AU (1) AU2008344909B2 (pt)
BR (1) BRPI0818459A2 (pt)
CA (1) CA2702478C (pt)
CO (1) CO6270384A2 (pt)
EA (1) EA201070483A1 (pt)
EC (1) ECSP10010167A (pt)
IL (1) IL205095A0 (pt)
MX (1) MX2010004211A (pt)
NZ (1) NZ584555A (pt)
SG (1) SG185273A1 (pt)
UA (1) UA100393C2 (pt)
WO (1) WO2009084021A2 (pt)
ZA (1) ZA201002615B (pt)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1005519A2 (pt) * 2009-02-20 2016-02-23 Micro Labs Ltd produto de prostaglandina estável ao armazenamento.
FR2961694B1 (fr) * 2010-06-29 2013-01-25 Thea Lab Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur
US9907826B2 (en) * 2011-12-07 2018-03-06 Allergan, Inc. Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
US9409952B2 (en) 2011-12-28 2016-08-09 Chugai Seiyaku Kabushiki Kaisha Peptide-compound cyclization method
EP2630952A1 (en) * 2012-02-23 2013-08-28 Novagali Pharma S.A. Self-preserved oil dispersions comprising boric acid
CN105012231A (zh) * 2014-04-30 2015-11-04 四川科伦药物研究院有限公司 一种包含PGF2α衍生物的稳定性良好的眼用制剂及其制备方法
US20190380958A1 (en) * 2016-12-28 2019-12-19 Chugai Seiyaku Kabushiki Kaisha Self-emulsifying drug formulation for improving membrane permeability of compound
CN110996954A (zh) * 2017-06-08 2020-04-10 眼科治疗有限责任公司 低剂量的溴莫尼定组合及其用途
SI3593788T1 (sl) 2018-07-12 2021-03-31 Nicox S.A. Oftalmični sestavki vsebujoči prostamid, ki sprošča dušikov monoksid
US20210251970A1 (en) 2018-10-10 2021-08-19 Presbyopia Therapies Inc Compositions and methods for storage stable ophthalmic drugs
EP3982930A1 (en) * 2019-06-11 2022-04-20 SIFI S.p.A. Microemulsion compositions
US11786538B2 (en) 2019-12-11 2023-10-17 Somerset Therapeutics, Llc Low benzalkonium chloride bimatoprost ophthalmic compositions with effective penetration and preservation properties
TWI896607B (zh) * 2020-03-31 2025-09-11 日商參天製藥股份有限公司 填充於樹脂製容器之含銀鹽眼科用水性組合物
CN116847841A (zh) * 2020-10-13 2023-10-03 伦茨治疗股份有限公司 稳定眼科药物的组合物和储存方法
EP4433053A4 (en) 2021-11-17 2025-09-17 Lenz Therapeutics Operations Inc ACECLIDINE DERIVATIVES, THEIR COMPOSITIONS AND METHODS OF USE
JP2022120120A (ja) * 2022-06-13 2022-08-17 東亜薬品株式会社 眼科用水性組成物及びプロスタグランジンＦ２α誘導体の含量の低下を抑制する方法
WO2024015959A1 (en) 2022-07-15 2024-01-18 Praful Doshi Methods of making and using contact lenses including medicaments and stabilizers of labile components such as drugs
US12414942B1 (en) 2024-03-15 2025-09-16 Lenz Therapeutics Operations, Inc. Compositions, methods, and systems for treating presbyopia

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5631287A (en) * 1994-12-22 1997-05-20 Alcon Laboratories, Inc. Storage-stable prostaglandin compositions
DE69922916T2 (de) * 1998-07-14 2005-06-09 Alcon Manufacturing Ltd., Fort Worth Polypropylenbasierte behälter für prostaglandin-enthaltende produkte
KR100350179B1 (ko) * 1998-09-23 2002-08-27 구주제약주식회사 Ｓｅｄｄｓ로 제제화한 발기부전치료용 주입액제
JP3876355B2 (ja) * 2000-09-13 2007-01-31 参天製薬株式会社 点眼液
US20040185068A1 (en) * 2003-03-18 2004-09-23 Zhi-Jian Yu Self-emulsifying compositions, methods of use and preparation
JP4092507B2 (ja) * 2003-07-31 2008-05-28 参天製薬株式会社 プロスタグランジン含有製品
US20050049311A1 (en) * 2003-09-03 2005-03-03 Pharmacia & Upjohn Company Medicinal products comprising prostaglandin compositions and methods of packaging such compositions
EP1655021B1 (en) * 2004-11-09 2008-10-29 Novagali Pharma SA Oil-in-water type emulsion with low concentration of cationic agent and positive zeta potential
CA2586074C (en) * 2004-11-09 2013-07-23 Novagali Pharma Sa Ophthalmic oil-in-water type emulsion with stable positive zeta potential
BRPI0708891A2 (pt) * 2006-03-13 2011-06-28 R Tech Ueno Ltd composição aquosa
CA2672973C (en) * 2006-12-21 2016-03-08 Novagali Pharma Sa Process for manufacturing ophthalmic oil-in-water emulsions
US20080234376A1 (en) * 2007-03-21 2008-09-25 Taiwan Liposome Company (A Taiwan Corporation) Emulsion composition comprising prostaglandin e1
FR2918891B1 (fr) * 2007-07-20 2009-09-25 Thea Sa Lab Solution ophtalmique a base de prostaglandines sans conservateur

Also Published As

Publication number Publication date
ZA201002615B (en) 2010-12-29
WO2009084021A2 (en) 2009-07-09
ECSP10010167A (es) 2010-06-29
NZ584555A (en) 2012-03-30
EP2197449A2 (en) 2010-06-23
AU2008344909A1 (en) 2009-07-09
AU2008344909B2 (en) 2013-06-06
CO6270384A2 (es) 2011-04-20
CA2702478C (en) 2014-12-09
UA100393C2 (ru) 2012-12-25
CA2702478A1 (en) 2009-07-09
JP2011508724A (ja) 2011-03-17
IL205095A0 (en) 2010-11-30
KR101510185B1 (ko) 2015-04-10
MX2010004211A (es) 2010-06-30
US9629852B2 (en) 2017-04-25
EP2197449A4 (en) 2013-10-09
KR20100087107A (ko) 2010-08-03
WO2009084021A3 (en) 2009-12-03
US20150290216A1 (en) 2015-10-15
US20100137432A1 (en) 2010-06-03
EA201070483A1 (ru) 2010-10-29
JP5646331B2 (ja) 2014-12-24
SG185273A1 (en) 2012-11-29
US9539262B2 (en) 2017-01-10
CN101835473B (zh) 2012-12-05
CN101835473A (zh) 2010-09-15

Similar Documents

Publication Publication Date Title
BRPI0818459A2 (pt) Composição farmacêutica adequada para uso oftálmico.
BRPI0819218A2 (pt) Métodos, estojos e composições para administração de compostos farmacêuticos
LTPA2018005I1 (lt) Farmacinė kompozicija
BRPI0811635A2 (pt) Compostos de arilazol-2-il cianoetilamino, métodos para fazê-los e métodos para o uso dos mesmos
BRPI0821668A2 (pt) Uso
BRPI0815709A2 (pt) composro, composição farmacêutica, e, uso de um composto.
BRPI0811979A2 (pt) Formulação para vacinas de meningite
BRPI0721651A2 (pt) Composição farmacêutica
BRPI0813237A2 (pt) Composto, método para preparar o composto, composição, medicamento, e, uso do composto.
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0922233A2 (pt) compostos, composições farmacêiticas e métodos para uso no tratamento de síndromes metabólicas.
BRPI0813680A2 (pt) AGENTES DE iRNA, COMPOSIÇÃO FARMACÊUTICA COMPREENDENDO OS MESMOS, BEM COMO SEU USO.
BRPI0812354A2 (pt) Composição farmacêutica não-aquosa.
DK2120884T3 (da) Farmaceutisk sammensætning
BRPI0818483A2 (pt) Método para preparar uma composição farmacêutica, composição farmacêutica, e, uso da mesma.
ITMI20080003A1 (it) Composizioni per uso oftalmico
BRPI0808813A2 (pt) método para a preparação de compostos de borracha, e, uso de compostos
PT2209464E (pt) Composição farmacêutica antimalárica
BRPI0911772A2 (pt) composto, composição farmacêutica, e, uso do composto.
PT1978981E (pt) Composições para uso vaginal
BRPI0903914A2 (pt) Uso de um composto, método para analisar a eficácia de uma composição de liberação prolongada, e, composição farmacêutica.
BRPI0813587A2 (pt) Composto, uso do mesmo, e, composição farmacêutica
BRPI0807724A2 (pt) Composição para uso na odontologia
BRPI0812000A2 (pt) Métodos e composições para administração de oxibutinina
BRPI0810986A2 (pt) Composição farmacêutica para uso como um laxativo

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]

Free format text: MANTIDO O INDEFERIMENTO UMA VEZ QUE NAO FOI APRESENTADO RECURSO DENTRO DO PRAZO LEGAL